Axsome Therapeutics, Inc.
AXSMNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $8.38B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $123.42$260.19
- Volume (live)
- -
- Avg. volume (3M)
- 777.04K
Axsome Therapeutics (AXSM) Stock Price & Financial Analysis
Axsome Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $156.09 - $160.43 |
|---|---|
| 52-Week High | $260.19 |
| 52-Week Low | $123.42 |
| Open | $160.43 |
| Volume (last close) | 873.08K |
| Average Volume (3M) | 777.04K |
| Revenue (TTM) | 776.57M |
|---|---|
| Net Income (TTM) | -191.64M |
| Free Cash Flow (TTM) | -71.96M |
| EPS (TTM) | −$3.76 |
| Profit Margin | -24.68% |
| Operating Margin | -22.70% |
| Return on Equity (ROE) | -230.05% |
| Debt to Equity | 2.26 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 8.38B |
|---|---|
| Shares Outstanding | 51.80M |
| Price to Sales (P/S) | 10.79 |
| Price to Book (P/B) | 100.60 |
| EV/EBITDA | -46.44 |
| 50-Day MA | $200.02 |
|---|---|
| 200-Day MA | $200.48 |
| 1-Year Change | +29.43% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Axsome Therapeutics at a Glance
As of the Oct 16, 2026 close, Axsome Therapeutics (AXSM) has a market capitalization of $8.38B. The stock trades at 10.8× sales. Over the trailing twelve months it lost $191.64M on revenue of $776.57M and burned $71.96M of free cash flow. Revenue grew 56.9% year over year.
As of its latest reported balance sheet, it holds $319.85M in cash and securities against $187.96M of debt, a net cash position of $131.89M.
Axsome Therapeutics does not currently pay a dividend.
The share price is up 29.4% over the past year. At $157.14 (the Oct 16, 2026 close) it sits within its 52-week range of $123.42 to $260.19, below its 200-day moving average of $200.48.
Based on 19 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $287.87, 83.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Axsome Therapeutics
What is the current stock price for AXSM?
As of the Oct 16, 2026 close, AXSM stock trades at $157.14. The 52-week range is $123.42–$260.19, with a day range of $156.09–$160.43.
What is the P/E ratio for AXSM?
The P/E ratio (Price-to-Earnings) for AXSM is shown in the Key Statistics section. This valuation metric helps compare Axsome Therapeutics, Inc. to industry peers.
Does AXSM pay dividends?
Axsome Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AXSM?
Based on ratings from 19 professional analysts over the last 90 days, the consensus for AXSM is Buy. The average 12-month price target is $287.87, a 83.2% upside from the Oct 16, 2026 close of $157.14.
What is the market cap of AXSM?
As of the Oct 16, 2026 close, Axsome Therapeutics's market capitalization is $8.14B, classifying it as a mid-cap company. Axsome Therapeutics operates in the Healthcare sector within the Biotechnology industry.